Alzheimer's Disease and Dementia

Latest

Predicted Prevalence of Alzheimer Disease in the United States by 2060

Predicted Prevalence of Alzheimer Disease in the United States by 2060

In the United States, it is estimated that 15 million people will have clinical Alzheimer disease or mild cognitive impairment by 2060.

Dementia Risk Not Associated With Proton Pump Inhibitor Use

Dementia Risk Not Associated With Proton Pump Inhibitor Use

Dementia risk was associated with neither proton pump inhibitor exposure nor duration of use.

Memory Scores Have Limited Value as Early Alzheimer Disease Screening Tools

Memory Scores Have Limited Value as Early Alzheimer Disease Screening Tools

Low memory scores are not a good tool for measure early Alzheimer's disease in people without dementia.

Nonoptimal Serum Magnesium Levels Associated With Incident Dementia

Nonoptimal Serum Magnesium Levels Associated With Incident Dementia

Low and high serum magnesium levels were shown to be associated with increased risk of all-cause dementia.

Alzheimer Disease Progression in Patients With MCI Predicted by EEG, Language Deficits

Alzheimer Disease Progression in Patients With MCI Predicted by EEG, Language Deficits

Language deficits as well as EEG recordings may be of value for predicting Alzheimer's disease in patients with mild cognitive impairment.

Abnormal MRI and CSF Findings May Predict Risk for Alzheimer Disease

Abnormal MRI and CSF Findings May Predict Risk for Alzheimer Disease

In patients with mild cognitive impairment, CSF and MRI findings are highly predicitve of Alzheimer disease and dementia risk.

No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia

No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia

More research is needed on the correlation between personality and Alzheimer disease biomarkers.

Intepirdine Does Not Demonstrate Significant Improvement for Alzheimer Disease

Intepirdine Does Not Demonstrate Significant Improvement for Alzheimer Disease

Intepirdine did not meet efficacy endpoints in a Phase 3 trial for Alzheimer disease.

Alzheimer Disease Risk Not Increased With Androgen Deprivation Therapy

Alzheimer Disease Risk Not Increased With Androgen Deprivation Therapy

There is no significant risk of Alzheimer's disease or dementia for men getting androgen deprivation therapy.

Lower Levels of Dementia Associated With Lithium in Drinking Water

Lower Levels of Dementia Associated With Lithium in Drinking Water

Researchers found that patients with a diagnosis of dementia had a significantly different lithium exposure than controls.

Sign Up for Free e-newsletters